CagA C-terminal variations in Helicobacter pylori strains from Colombian patients with gastric precancerous lesions

Clinical Microbiology and Infection

Volumn 16, Issue 4, 2010, Pages 369-378

  Sicinschi, L A ^a   Correa, P ^a   Peek, R M ^a   Camargo, M C ^a   Piazuelo, M B ^a   Romero Gallo, J ^a   Hobbs, S S ^a   Krishna, U ^a   Delgado, A ^a   Mera, R ^a   Bravo, L E ^b   Schneider, B G ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSIDAD DEL VALLE   (Colombia)

Author keywords

CagA; CagA 3 region; CagA multimerization motif; EPIYA; ESS; H. pylori; WSS

Indexed keywords

ALANINE; CAGA PROTEIN; GLUTAMIC ACID; ISOLEUCINE; PROLINE; PROTEIN TYROSINE PHOSPHATASE SHP 2; TYROSINE;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; BACTERIAL STRAIN; CANCER RISK; CARBOXY TERMINAL SEQUENCE; COLOMBIA; CONTROLLED STUDY; DISEASE CLASSIFICATION; DYSPEPSIA; GEOGRAPHICAL VARIATION (SPECIES); HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRECANCER; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN MULTIMERIZATION; STOMACH BIOPSY; STOMACH CANCER; STRAIN DIFFERENCE;

HELICOBACTER PYLORI;

EID: 77950958214     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02811.x     Document Type: Article

References (35)

1. Covacci A, Telford JL, Del Giudice G. Helicobacter pylori virulence and genetic geography. Science 1999, 284:1328-1333.
2. Cover TL, Blaser MJ. Helicobacter pylori factors associated with disease. Gastroenterology 1999, 117:257-260.
3. Censini S, Lange C, Xiang Z. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996, 93:14648-14653.
4. Covacci A, Censini S, Bugnoli M. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Nat Acad Sci USA 1993, 90:5791-5795.
5. Tummuru MKR, Cover TL, Blaser MJ. Cloning and expression of a high-molecular mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun 1993, 61:1799-1809.
6. Blaser MJ, Perez-Perez GI, Kleanthou TL. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995, 55:2111-2115.
7. Parsonnet J, Friedman GD, Orentreich N. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997, 40:297-301.
8. Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995, 19:S37-S43.
9. Asahi M, Azuma T, Ito S. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med 2000, 191:593-602.
10. Backert S, Ziska E, Brinkmann V. Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus. Cell Microbiol 2000, 2:155-164.
11. Backert S, Moese S, Selbach M. Phosphorylation of tyrosine 972 of the Helicobacter pylori CagA protein is essential for induction of a scattering phenotype in gastric epithelial cells. Mol Microbiol 2001, 42:631-644.
12. Selbach M, Moese S, Hauck CR. Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J Biol Chem 2002, 277:6775-6778.
13. Hatakeyama M, Higashi H. Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis. Cancer Sci 2005, 96:835-843.
14. Tammer I, Brandt S, Hartig R. Activation of Abl by Helicobacter pylori: a novel kinase for CagA and crucial mediator of host cell scattering. Gastroenterology 2007, 132:1309-1319.
15. Yamazaki S, Yamakawa A, Ito Y. The CagA protein of Helicobacter pylori is translocated into epithelial cells and binds to SHP-2 in human gastric mucosa. J Infect Dis 2003, 187:334-337.
16. Higashi H, Tsutsumi R, Fujita A. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Nat Acad Sci USA 2002, 99:14428-14433.
17. Yamaoka Y, Kodama T, Kashima K. Variants of the 3′ region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J Clin Microbiol 1998, 36:2258-2263.
18. Yamaoka Y, El-Zimaity HMT, Gutierrez O. Relationship between the cagA 3′ repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology 1999, 117:342-349.
19. Naito M, Yamazaki T, Tsutsumi R. Influence of EPIYA-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA. Gastroenterology 2006, 130:1181-1190.
20. Argent RH, Kidd MS, Owen RJ. Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 2004, 127:514-523.
21. Ren S, Higashi H, Lu H. Structural basis and functional consequence of Helicobacter pylori CagA multimerization in cells. J Biol Chem 2006, 281:32344-32352.
22. Camargo MC, Yepez MC, Ceron C. Age at acquisition of Helicobacter pylori infection: comparison of two areas with contrasting risk of gastric cancer. Helicobacter 2004, 9:262-270.
23. Bravo LE, van Doorn LJ, Realpe JL. Virulence-associated genotypes of Helicobacter pylori: do they explain the African Enigma? Am J Gastroenterol 2002, 97:2839-2842.
24. Sicinschi LA, Correa P, Peek RM. Helicobacter pylori genotyping and sequencing using paraffin-embedded biopsies from residents of Colombian areas with contrasting gastric cancer risks. Helicobacter 2007, 12:624-634.
25. van Doorn LJ, Figueiredo C, Rossau R. Typing of the Helicobacter pylori vacA gene and detection of the cagA gene by PCR and reverse hybridization. J Clin Microbiol 1998, 36:1271-1276.
26. Dixon MF, Genta RM, Yardley JH. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996, 20:1161-1181.
27. Rugge M, Correa P, Dixon MF. Gastric dysplasia-the Padova international classification. Am J Surg Pathol 2000, 24:167-176.
28. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 2004, 4:688-694.
29. Higashi H, Nakaya A, Tsutsumi R. Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J Biol Chem 2004, 279:17205-17216.
30. Tsutsumi R, Higashi H, Higuchi M. Attenuation of Helicobacter pylori CagA × SHP-2 signaling by interaction between CagA and C-terminal Src kinase. J Biol Chem 2003, 278:3664-3670.
31. Correa P, Haenszel W, Cuello C. A model for gastric cancer epidemiology. Lancet 1975, 2:58-60.
32. Azuma T, Yamakawa A, Yamazaki S. Correlation between variation of the 3′ region of the cagA gene in Helicobacter pylori and disease outcome in Japan. J Infect Dis 2002, 186:1621-1630.
33. Reyes-Leon A, Atherton JC, Argent RH. Heterogeneity in the activity of Mexican Helicobacter pylori strains in gastric epithelial cells and its association with diversity in the cagA gene. Infect Immun 2007, 75:3445-3454.
34. Devi SM, Ahmed I, Khan AA. Genomes of Helicobacter pylori from native Peruvians suggest admixture of ancestral and modern lineages and reveal a western type cag-pathogenicity island. BMC Genomics 2006, 7:191.
35. Occhialini A, Marais A, Urdaci M. Composition and gene expression of the cag pathogenicity island in Helicobacter pylori strains isolated from gastric carcinoma and gastritis patients in Costa Rica. Infect Immun 2001, 69:1902-1908.